Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (SHSE: 600436)
Health Care · Pharmaceuticals · CN
CN¥124.10
-6.40% today · -42.0% 1Y
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (SHSE: 600436) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $11.14B and employs 2,886 people.
Over the last twelve months the share price has lost 42.0%, trading between 105.98 and 215.02.
Tweenvest scores Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. across four factors: quality 76/100, value 62/100, growth 38/100, dividend 62/100. Its strongest factor is quality.
600436 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.14B
- Revenue (TTM)
- $1.25B
- P/E
- 39.37
- EPS
- 3.15
- Dividend yield
- 2.39%
- Beta (5Y)
- 0.24
- 52-week high
- CN¥215.02
- 52-week low
- CN¥105.98
- Avg volume (3M)
- —
- Shares outstanding
- 603.32M
- Employees
- 2,886
- Next earnings
- —
About Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. is a Chinese company, headquartered in Zhangzhou, that specializes in the production and distribution of traditional Chinese medicines. Its offerings, predominantly sold under the renowned Pien Tze Huang brand, reach consumers both domestically within China and across international markets. Beyond its core pharmaceutical products, the company's expansive portfolio encompasses health and wellness items, beauty care products, household chemical goods, a variety of medical devices, and nutritional supplements. The firm operates as a subsidiary of Zhangzhou Jiulongjiang Group Co., Ltd.
- ISIN
- CNE000001F21
- Founded
- 1956
- Listed since
- Jun 16, 2003
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.